People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Regenerx Biopharmaceuticals Inc | — | Pharmaceuticals | Series A | $19.8M | $40.3M | 2011 |
R. DON L. ELSEY at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside R. DON L. ELSEY on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| R Don Elsey | 1 | 2 |
| Allan Goldstein | 1 | 2 |
| Mauro Bove | 1 | 2 |
| C Neil Lyons | 1 | 2 |
| Joseph McNay | 1 | 2 |
| Jospeh McNay | 1 | 1 |
| Joseph C McNay | 1 | 1 |
| Allan L Goldstein | 1 | 1 |
| Mauro L Bove | 1 | 1 |
| L. THOMPSON L. BOWLES | 1 | 1 |
| Joseph Don McNay | 1 | 1 |
| Richard Hindin | 1 | 1 |
| David Crockford | 1 | 1 |
| L. Thompson Bowles | 1 | 1 |
| J.J. Finkelstein | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.